TPST1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.3294998435498E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.14379966503964E-10 |
Normal-vs-Stage2 |
4.76339967470096E-10 |
Normal-vs-Stage3 |
2.38269959318416E-10 |
Normal-vs-Stage4 |
7.20350001870429E-09 |
Stage1-vs-Stage2 |
3.105000E-01 |
Stage1-vs-Stage3 |
7.002200E-01 |
Stage1-vs-Stage4 |
9.669200E-01 |
Stage2-vs-Stage3 |
6.239800E-01 |
Stage2-vs-Stage4 |
4.757800E-01 |
Stage3-vs-Stage4 |
7.987400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.5054003316427E-10 |
Normal-vs-AfricanAmerican |
4.98500019041614E-10 |
Normal-vs-Asian |
7.84340000000716E-05 |
Caucasian-vs-AfricanAmerican |
4.115000E-01 |
Caucasian-vs-Asian |
5.114400E-01 |
AfricanAmerican-vs-Asian |
7.031600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.1254000215929E-11 |
Normal-vs-Female |
3.40070005488968E-09 |
Male-vs-Female |
5.572000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.40219999961766E-07 |
Normal-vs-Age(41-60Yrs) |
1.15800036226688E-10 |
Normal-vs-Age(61-80Yrs) |
5.400000446798E-10 |
Normal-vs-Age(81-100Yrs) |
1.169120E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.728000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.916400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.825800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.775400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.949000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.880400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.68340000000056E-05 |
Normal-vs-Grade 2 |
1.71490044387212E-10 |
Normal-vs-Grade 3 |
1.71159975081991E-10 |
Normal-vs-Grade 4 |
7.25450000071959E-08 |
Grade 1-vs-Grade 2 |
7.910800E-01 |
Grade 1-vs-Grade 3 |
9.444800E-01 |
Grade 1-vs-Grade 4 |
5.725400E-01 |
Grade 2-vs-Grade 3 |
6.958600E-01 |
Grade 2-vs-Grade 4 |
4.131600E-01 |
Grade 3-vs-Grade 4 |
3.343400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.51060291947647E-11 |
Normal-vs-ccB subtype |
8.69969984940155E-10 |
ccA subtype-vs-ccB subtype |
8.993700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.44590003806167E-09 |
Normal-vs-N1 |
7.415000E-03 |
N0-vs-N1 |
6.027800E-01 |
|
|